Novasep-PharmaZell commits nearly$7.5m to boosting API capacity
The contract development and manufacturing organization plans to invest â7.3m to expand and upgrade API production capacity at its Mourenx, France facility.
The contract development and manufacturing organization plans to invest â7.3m to expand and upgrade API production capacity at its Mourenx, France facility.
Sanofi has completed the spin-out of its pharma ingredients business EuroAPI, with shares in the new company rising more than 3% on its starting price […]
An expert from the company discusses ahead of his CPhI North America presentation how tomorrowâs drugs canât all be formulated with yesterdayâs excipients.
The 2022 edition of the Highly Potent Active Pharmaceutical Ingredients Summit (June 28 to 30 in Boston) will take on a range of topics, including […]
The union of the active pharmaceutical ingredient supplier and contract development and manufacturing organization will create a global services company.
A representative from IFF Pharma Solutions talks about significant challenges in drug development and improvements the industry can implement to overcome them.
The CPhI Worldwide exhibitor will show Syloid XDP, a silica carrier designed to convert liquid, waxy, or oily active ingredients into free-flowing powders.
An expert from the specialty chemicals firm (and CPhI Worldwide speaker) explains trends and developments in excipients and how they drive advancements.
The pjarmaceutical excipient, intended for use in the formulation of flash orally dissolving tablets, is designed to disintegrate in less than 10 seconds.
A leader from the excipients firm discusses how ODTs appeal to seniors and patients on the go, and the formulation-related challenges with such tablets.
A representative from Clarivate explains how supply chain vulnerabilities can hurt stakeholders, including patientsâand how one solution can close the gap.
The virtual event (scheduled June 22-24) will feature presentations from Bayer, Merck, GSK, Novartis, Takeda, FDA, WHO, and other notable organizations.
Shots: Bain Capital and Cinven to acquire Lonza’s specialty ingredients business and operations for an enterprise value of $4.7B. The transaction is expected to close […]
WuXi STA will purchase Bristol Myers Squibbâs manufacturing facility in Couvet, Switzerland: giving the CDMO its first facility in Europe.
The global pharmaceutical firm expects big things from its newly formed active pharmaceutical ingredients company, to be led by new CEO Karl Rotthier.
According to an executive from the drug development services company, pharma professionals should pay close attention to supply chain continuity and safety in the coming […]
A leader from the STA Pharmaceutical subsidiary of WuXI AppTec talks about the dynamic HPAPI market and whatâs ahead for their operation.
The 17th annual awards program, announced during the CPhI Festival of Pharma virtual event, hails professionals from various aspects of the industry.
The pharma ingredients company has named veteran Scott Thomson, a 29-year veteran with chemicals firm BASF, to its executive leadership team.
The CPhI Festival of Pharma exhibitor will work with Ligand to increase output of Captisol, a key ingredient in Gileadâs Veklury COVID-19 treatment
The pharma ingredients provider discusses new products, supply-chain obstacles, and what the future of the industry might hold, ahead of the online event.
The imaging companyâs newly launched division, created to produce drug ingredients, received the loan from the US International Development Finance Corp.
The Committee for Human Medicinal Products (CHMP) of the European Medicines Agency (EMA) has issued its final opinion on measures for companies to take that […]
Copyright © 2024 | WordPress Theme by MH Themes